These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 4740876)

  • 1. Studies with some novel uricosuric agents and their metabolites: correlation between clinical activity and drug-induced displacement of urate from its albumin-binding sites.
    Schlosstein LH; Kippen I; Whitehouse MW; Bluestone R; Paulus HE; Klinenberg JR
    J Lab Clin Med; 1973 Sep; 82(3):412-8. PubMed ID: 4740876
    [No Abstract]   [Full Text] [Related]  

  • 2. Displacement by uricosuric agents of sodium urate bound to human serum albumin.
    Campion DS; Bluestone R; Klinenberg JR
    Biochem Pharmacol; 1974 May; 23(11):1653-7. PubMed ID: 4408019
    [No Abstract]   [Full Text] [Related]  

  • 3. Increasing excretion of urate with displacing agents in man.
    Whitehouse MW; Kippen I; Klinenberg JR; Schlosstein L; Campion DS; Bluestone R
    Ann N Y Acad Sci; 1973 Nov; 226():309-18. PubMed ID: 4520399
    [No Abstract]   [Full Text] [Related]  

  • 4. [Effect of benzbromarone on serum uric acid level and uric acid excretion of patients with gout].
    Zöllner N; Griebsch A; Fink JK
    Dtsch Med Wochenschr; 1970 Nov; 95(48):2405-12. PubMed ID: 5480261
    [No Abstract]   [Full Text] [Related]  

  • 5. Uricosuric therapy and urate solubility in blood and urine.
    Gröbner W; Zöllner N
    Postgrad Med J; 1979; 55 Suppl 3():26-31. PubMed ID: 504037
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Uricosuric effect of glyceryl guaiacolate.
    Ramsdell CM; Postlethwaite AE; Kelley WN
    J Rheumatol; 1974 Mar; 1(1):114-6. PubMed ID: 4617771
    [No Abstract]   [Full Text] [Related]  

  • 7. [Benziodarone in the basic treatment of gout].
    Ryckewaert A; Puel M; Kuntz D
    Rev Rhum Mal Osteoartic; 1972 Jan; 39(1):33-9. PubMed ID: 5079688
    [No Abstract]   [Full Text] [Related]  

  • 8. The pharmacology of hypouricemic effect of benzbromarone.
    Sinclair DS; Fox IH
    J Rheumatol; 1975 Dec; 2(4):437-45. PubMed ID: 1206675
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Halofenate. Its selection and trial as a primary uricosuric agent.
    Bluestone R; Campion D; Klinenberg JR
    Arthritis Rheum; 1975; 18(6 Suppl):859-62. PubMed ID: 1106434
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Changes in the serum concentration of uric acid under the effect of benzbromaronum].
    Mertz DP
    Munch Med Wochenschr; 1969 Feb; 111(9):491-5. PubMed ID: 5818966
    [No Abstract]   [Full Text] [Related]  

  • 11. Urate binding: a clue to the pathogenesis of gout.
    Bluestone R; Kippen I; Campion D; Klinenberg J; Whitehouse M
    J Rheumatol; 1974 Jun; 1(2):230-5. PubMed ID: 4457646
    [No Abstract]   [Full Text] [Related]  

  • 12. Uricosuric activity of suxibuzone, a new phenylbutazone derivative.
    Erill S; Laporte J
    Arch Farmacol Toxicol; 1975 Mar; 1(1):43-6. PubMed ID: 1231648
    [No Abstract]   [Full Text] [Related]  

  • 13. Impact of noncompliance with urate-lowering drug on serum urate and gout-related healthcare costs: administrative claims analysis.
    Halpern R; Mody RR; Fuldeore MJ; Patel PA; Mikuls TR
    Curr Med Res Opin; 2009 Jul; 25(7):1711-9. PubMed ID: 19485724
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Hyperuricemia and gout; treatment of an acute attack of gout].
    Gast LF; Cats A; van Romunde LK
    Ned Tijdschr Geneeskd; 1983 Dec; 127(49):2235-7. PubMed ID: 6656915
    [No Abstract]   [Full Text] [Related]  

  • 15. [Observations on a random group of gout patients].
    Einaudi G; Marrazzi G; Pecchiura G
    Reumatismo; 1972; 24(1):21-9. PubMed ID: 4671625
    [No Abstract]   [Full Text] [Related]  

  • 16. Drug treatment of gout.
    Kelley WN; Wyngaarden JB
    Semin Drug Treat; 1971 Sep; 1(2):119-47. PubMed ID: 4949305
    [No Abstract]   [Full Text] [Related]  

  • 17. Restoration of the uricosuric effect of probenecid after triglycylvasopressine administration in a gouty patient.
    Decaux G; Soupart A; Musch W; Hannotier P; Prospert F
    Clin Nephrol; 1998 Oct; 50(4):262-5. PubMed ID: 9799074
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Uricosuric effect of a phenylbutazone derivative, cetophenylbutazone].
    Mugler A
    Rev Rhum Mal Osteoartic; 1971 Jan; 38(1):33-9. PubMed ID: 5549166
    [No Abstract]   [Full Text] [Related]  

  • 19. A simple method of selecting gout patients for treatment with uricosuric agents, using spot urine and blood samples.
    Yamamoto T; Moriwaki Y; Takahashi S; Tsutsumi Z; Ka T; Fukuchi M; Hada T
    J Rheumatol; 2002 Sep; 29(9):1937-41. PubMed ID: 12233889
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Management of gouty arthritis and hyperuricemia.
    Owen DS; Toone EC; Irby R
    GP; 1968 Oct; 38(4):133-8. PubMed ID: 5679519
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.